Volume 28, Number 7—July 2022
Dispatch
Determining Infected Aortic Aneurysm Treatment Using Focused Detection of Helicobacter cinaedi
Saito Jien
, Rimbara Emiko, Inaguma Shingo, Hasegawa Chihiro, Kamiya Shinji, Mizuno Akihiro, Sone Yoshiaki, Ogawa Tatsuhito, Numata Yukihide, Takahashi Satoru, and Asano Miki
, Rimbara Emiko, Inaguma Shingo, Hasegawa Chihiro, Kamiya Shinji, Mizuno Akihiro, Sone Yoshiaki, Ogawa Tatsuhito, Numata Yukihide, Takahashi Satoru, and Asano Miki
Table 2
Bacteriological examination, method of treatment, and outcomes for 10 patients with infected aortic aneurysms with or without Helicobacter cinaedi, Aichi, Japan, September 2017–January 2021*
| Patient no. | Age, y/sex | Location | Blood cultures | ID | Comorbidity | Procedure‡ | Antimicrobial use period |
Outcome |
|---|---|---|---|---|---|---|---|---|
| H. cinaedi group, n = 4† | ||||||||
| 1 | 72/M | Aortic arch | 75.3/negative | ST6 | DM | TAR (positive) | 6 mo | Survival at 4 y |
| 2 | 64/F | Right common iliac | Negative | Unknown | DM | Y graft (negative) | 6 mo | Survival at 3 y |
| 3 | 83/M | Infrarenal aorta | 86.5/160.8 | ST18 | Malignant lymphoma | EVAR (NA) | 6 mo | Survival at 2 y |
| 4 |
88/M |
Infrarenal aorta |
90.6/93.0 |
ST21 |
CKD |
Medical treatment only (NA) |
3 mo |
Survival at 1 y |
| Non–H. cinaedi group, n = 6§ | ||||||||
| 1 | 70/M | Infrarenal aorta | Negative | MSSA | None | Y graft | 6 mo | Survival at 4 y |
| 2 | 74/M | Infrarenal aorta | Negative | Listeria monocytogenes | None | Y graft | 6 mo | Survival at 4 y |
| 3 | 67/M | Infrarenal aorta | 12.6/12.6 | Enterobacter cloacae | AEF | Y graft | 6 mo | Survival at 3 y |
| 4 | 83/M | Infrarenal aorta | 12.3/12.3 | MSSA | DM | Y graft | 3 mo | Survival at 3 y |
| 5 | 86/F | Thoracoabdominal aorta | Negative | MSSA | None | Medical treatment only | 3 mo | Survival at 1 y |
| 6 | 80/M | Infrarenal aorta | 28.3/28.3 | Salmonella enteritidis | None | Y graft | Until death | Death at POD 5 |
*DM, diabetes mellitus; CKD, chronic kidney disease; TAR, total arch replacement; EVAR, endovascular aortic repair; NA, not applicable; MSSA, methicillin-susceptible Staphylococcus aureus; AEF, aorto-enteric fistula; POD, postoperative day; ST, sequence type. †16S RNA results were positive for all patients. ‡Y graft replacement for abdominal aortic aneurysm. §Tissue culture results for all patients returned in 1 d; patient 5 had an abscess.
Page created: May 05, 2022
Page updated: June 18, 2022
Page reviewed: June 18, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Content Credential